en

PRODUCT DETAIL

Tyruko 300 mg infúzny koncentrát

Code 4509E
MA number EU/1/23/1745/001
Product Form: con inf 1x15 ml/300 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA23 Natalizumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 22.09.2023
Validity: 22.09.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.01.2024
eu-flag.png sk-flag.png